Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Neoplasms × Cyclophosphamide × Clear all

Sponsor

Conditions

Burkitt Lymphoma 3 Breast Neoplasms 3 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Diseases 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1 Anemia 1

Interventions

trametinib 3 encorafenib 3 dabrafenib 3 Oxaliplatin 3 zolbetuximab 2 selpercatinib 2 pembrolizumab 2 lenvatinib 2 larotrectinib 2 binimetinib 2 Leucovorin 2 Fulvestrant 2 Fluorouracil 2 Cetuximab 2 Capecitabine 2 trastuzumab deruxtecan 1 tepotinib 1 telisotuzumab vedotin 1 ribociclib 1 repotrectinib 1 relatlimab 1 pralsetinib 1 pegaspargase 1 niraparib 1 dostarlimab 1 blinatumomab 1 avelumab 1 asparaginase erwinia chrysanthemi recombinant 1 adagrasib 1 Vemurafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡